-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-fullreport.pdf
February 14, 2018 - Metabolic Monitoring for Children and Adolescents on Antipsychotics
1
Metabolic Monitoring for Children and Adolescents
on Antipsychotics
Section 1. Basic Measure Information
1.A. Measure Name
Metabolic Monitoring for Children and Adolescents on Antipsychotics
1.B. Measure Number
0150
1.C. Measure Descripti…
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
January 01, 2014 - Follow-Up With Patient Family After Developmental Screening
Follow-up with Patient Family after Developmental
Screening
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up with Patient Family after Developmental Screening
1.B. Measure Number
0202
1.C. Measure Description
Please provide a non-tec…
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-205-fullreport.pdf
January 01, 2014 - Developmental Screening and Follow-Up: Follow-Up Referral Tracking
Developmental Screening and Follow-up:
Follow-up Referral Tracking
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Referral Tracking
1.B. Measure Number
0205
1.C. Measure Description
Please provide a non-technical descripti…
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-scd-ed-tech-specs.pdf
August 28, 2017 - Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease
Sickle Cell Disease
Measure 14: Appropriate Emergency Department Blood Testing for
Children with Sickle Cell Disease
Description
The percentage of children identified as having Sickle Cell Disease presenting to an emer…